HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Previous close
$25.88
Day range
$25.57 - $27.27
Year range
$21.68 - $44.32
Market cap
5.09B USD
Avg Volume
1.57M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.17M | 32.11% |
Operating expense | 174.22M | 21.31% |
Net income | -73.46M | 53.48% |
Net profit margin | -3.39K | 64.79% |
Earnings per share | -1.01 | -4.70% |
EBITDA | -171.07M | -21.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 447.77M | 16.67% |
Total assets | 794.38M | 57.72% |
Total liabilities | 1.88B | 1.25% |
Total equity | -1.08B | — |
Shares outstanding | 188.03M | — |
Price to book | -4.45 | — |
Return on assets | -52.52% | — |
Return on capital | -64.46% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -73.46M | 53.48% |
Cash from operations | 74.70M | 165.90% |
Cash from investing | 3.04M | -26.22% |
Cash from financing | -5.73M | -365.39% |
Net change in cash | 72.01M | 165.19% |
Free cash flow | -13.59M | 71.61% |
About
CEO
Founded
2015
Headquarters
Website
Employees
553
